CLinical evaluation of topical Unani pharmacopoeial formulation Tila-e-kalf in management of kalf (melasma) - Melasma ,ficus Carica ,prunus amygdalus

Jamia Hamdard0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Patients of all genders, belonging to 18 to 60 years age group and willing to participate in the trial voluntarily
•Clinically diagnosed patients of epidermal melasma using Woodâ??s lamp examination (340-400 nm)
•Patients willing to sign the informed consent form

•Pregnant and lactating women
•Female patient using oral contraceptives and hormonal intrauterine devices.
•Patients treated with tretinoin through the last 3 weeks
•Patients treated with hydroquinone through the last 6 months before entering the study
•Patients who have used any other bleaching creams or topical steroid creams for at least 4 weeks before entering the study
•Patients who undergone any laser therapies and chemical peeling
•Having used or consuming photosensitizing substances in past 4 weeks
•Patients with drug or alcohol addiction
•Patient having any endocrine or auto-immune disease
•Patients with Diabetes mellitus, renal insufficiency, severe liver, spleen, or heart diseases

发起方